Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Preferred Shares (2020 - 2023)

Historic Preferred Shares for Ovid Therapeutics (OVID) over the last 4 years, with Q3 2023 value amounting to $1.0.

  • Ovid Therapeutics' Preferred Shares changed 0.0% to $1.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 for FY2022, which is 0.0% changed from last year.
  • Latest data reveals that Ovid Therapeutics reported Preferred Shares of $1.0 as of Q3 2023, which was down 0.0% from $1.0 recorded in Q2 2023.
  • Ovid Therapeutics' Preferred Shares' 5-year high stood at $8.0 during Q1 2020, with a 5-year trough of $1.0 in Q1 2021.
  • Moreover, its 4-year median value for Preferred Shares was $1.0 (2021), whereas its average is $2.27.
  • As far as peak fluctuations go, Ovid Therapeutics' Preferred Shares crashed by 8750.0% in 2021, and later changed by 0.0% in 2022.
  • Over the past 4 years, Ovid Therapeutics' Preferred Shares (Quarter) stood at $3.0 in 2020, then plummeted by 66.67% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
  • Its Preferred Shares stands at $1.0 for Q3 2023, versus $1.0 for Q2 2023 and $1.0 for Q1 2023.